[1] ARROYO V，GINES P，GERBES AL，et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis[J]. Hepatology，1996，23:164-176.
[2] BOYER TD，ZIA P，REYNOLDS TB. Effect of indomethacin and prostaglandin A1 on renal function and plasma renin activity in alcoholic liver disease[J]. Gastroenterology，1979，77:215-222.
[3] PEREZ-AYUSO RM，ARROYO V，PLANAS R，et al. Randomized comparative study of efficacy of furosemide vs. spironolactone in nonazotemic cirrhosis with ascites[J]. Gastroenterology，1983，84:961-968.
[4] STANLEY MM，OCHI S，LEE KK，et al. Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites[J]. N Engl J Med，1989，321:1632-1638.
[5] GINES P，ARROYO V，QUINTERO E，et al. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites:results of a randomized study[J]. Gastroenterology，1987，93:234-241.
[6] RUNYON BA. Care of patients with ascites[J]. N Engl J Med，1994，330:337-342.
[7] RUNYON BA. Ascites and spontaneous bacterial peritonitis.in:Feldman M，Friedman LS，Brandt LJ，eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 8th ed[J]. Philadelphia，PA: Saunders；2006:1935-1964.
[8] RUNYON BA. Paracentesis of ascitic fuid:a safe procedure[J].Arch Intern Med，1986，146:2259-2261.
[9] GRABAU CM，CRAGO SF，HOFF LK，et al. Performance standards for the therapeutic abdominal paracentesis[J]. Hepatology，2004，40:484-488.
[10] GINES P，TITO L，ARROYO V，et al. Randomize study of therapeutic paracentesis with and without intravenous albumin in cirrhosis[J]. Gastroenterology，1988，94:1493-1502.
[11] GINES A，FERNANDEZ-ESPARRACH G，MONESCILLO A，et al. Randomized trial comparing albumin，dextran70，an polygeline in cirrhotic patients with ascites treated by paracentesis[J]. Gastroenterology，1996，111:1002-1010.
[12] SALO J，GINES A，GINES P，et al. Effect other therapeutic paracentesis on plasma volume and transvascular escape of albumin in patients with cirrhosis[J]. J Hepatol，1997，27:645-653.
[13] ROTHSCHILD M，ORATZ M，EVANS C，et al. Alterations in albumin metabolism after serum and albumin infusions[J]. J Clin Invest，1964，43:1874-1880.
[14] WILKINSON P，SHERLOCK S. The effect of repeated albumin infusions in patients with cirrhosis[J]. Lancet，1962，ii:1125-1129.
[15] PIETRANGELO A，PANDURO A，CHOWDHURY JR，et al. Albumin gene expression is down-regulated by albumin or macromolecule infusion in the rat[J]. J Clin Invest，1992，89:1755-1760.
[16] HAYNES GR，NAVICKIS RJ，WILKES MM. Albumin administration-what is evidence of clinical benefit A systematic review of randomize controlled trials[J]. Eur J Anaesth，2003，20:771-793.
[17] AMERICAN THORACIC SOCIETY. Evidence-based colloid use in the critical ill: American Thoracic Society Consensus Statement[J]. Am J Respir Cri Care Med，2004，170:1247-1259.
[18] CABRERA J，INGLADA L，QUINTERO E，et al. Large-volume paracentesis and intravenous saline:effects on the renin angiotensin system[J]. Hepatology，1991，14:1025-1028.
[19] CHRISTIDIS C，MAK F，RAMOS J，et al. Worsening of hepatic dysfunction as a consequence of repeated hydroxyethylstarch infusions[J]. J Hepatol，2001，35:726-732.
[20] SINGH V，KUMAR R，KANWAL C，et al. Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis:a randomized trial[J]. J Gastroenterol Hepatol，2006，21:303-307.
[21] CHOI CH，AHN SH，KIM DY，et al. Long-term clinical outcome of large volume paracentesis with intravenous albuminin patients with spontaneous bacterial peritonitis:a randomize prospective study[J]. J Gastroentero Hepatol，2005，20:1215-1222.
[22] HEUMAN DM，ABOU-ASSI SG，HABIB A，et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk forearly death[J].Hepatology，2004，40:802-810.
[23] ROSSLE M，OCHS A，GULBERG V，et al. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites[J]. N Engl J Med，2000，342:1701-1707.
[24] LEBREC D，GIUILY N，HADENGUE A，et al. Transjugular intrahepatic portosystemic shunts:comparison with paracentesis in patients with cirrhosis and refractory ascites:a randomized trial[J]. J Hepatol，1996，25:135-144.
[25] SANYAL AJ，GENNING C，REDDY RK，et al. The North American study for the treatment Of refractory ascites[J]. Gastroenterology，2003，124:634-641.
[26] SALERNO F，MERLI M，RIGGIO O，et al. Randomized controlled study of TIPS vs. paracentesis plus albumin in cirrhosis with severe ascites[J]. Hepatology，2004，40:629-635.
[27] SAAB S，NIETO JM，KY D，et al. TIPS versus paracentesis for cirrhotic patients with refractory ascites[J]. Cochrane Database Syst Rev，2004，3:CD004889.
[28] DELTENRE P，MATHURIN P，DHARANCY S，et al. Transjugular intrahepatic portosystemic shunt in refractory ascites:ameta-analysis[J]. Liver Int，2005，25:349-356.
[29] ALBILLOS A，BANARES R，GONZALEZ M，et al. A meta analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractoryascites[J]. J Hepatol，2005，43:990-996.
[30] D'AMICO G，LUCA A，MORABITO A，et al. Uncover transjugular intrahepatic portosystemic shunt for refractory ascites:a meta-analysis[J]. Gastroenterology，2005，129:1282-1293.
[31] SAAB S，NIETO JM，LEWIS SK，et al. TIPS versus paracentesis for cirrhotic patients with refractory ascites[J]. Cochrane Database Syst Rev，2006，4:CD004889.
[32] SALERNO F，CAMMA C，ENEA M，et al. Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data[J]. Gastroenterology，2007，133:825-834.
[33] POZZI M，CARUGO S，BOARI G，et al. Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites[J]. Hepatology，1997，26:1131-1137.
[34] AZOULAY D，CASTAING D，DENNISON A，et al. Transjugular intrahepatic shunt worsens the hyperdynamic circulatory state of the cirrhotic patient: preliminary report of a prospective study[J]. Hepatology，1994，19:129-132.
[35] RABIE R，CAZZANIGA M，SALERNO F，et al. The effect of cirrhotic cardiomyopathy on the post-TIPS outcome of patients treated for complications of portal hypertension [Abstract][J]. Hepatology，2006，44:444A.
[36] MICH LP，GULBERG V，BILZER M，et al. Transjugular intrahepatic portosystemic shunt for cirrhosis and ascites: effects in patients with organic or functional renal failure[J]. Scand J Gastroenterol，2000，35:654-657.
[37] BUREAU C，GARCIA-PAGAN JC，OTAL P，et al. Improved clinical outcome using polytetrafluoroethylenecoated stents for TIPS: results of a randomized study[J]. Gastroenterology，2004，126:469-475.
[38] ANGERMAYR B，CEJNA M，KOENIG F，et al. Survival in patients undergoing transjugular intrahepatic portosystemic shunt:ePTFE-covered stentgrafts versus bare stents[J]. Hepatology，2003，38:1043-1050.
[39] MALINCHOC M，KAMATH PS，GORDON FD，et al. A Modelto predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts[J]. Hepatology，2000，31:864-871.
[40] BOYER TD，HASKAL ZJ. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension[J]. Hepatology，2005，41:1-15.
[41] ROSEMURGY AS，ZERVOS EE，CLARK WC，et al. TIPS versus peritoneovenous shunt in the treatment of medically intractable ascites:a prospective and randomized trial[J]. Ann Surg，2004，239:883-891.
[42] PARK JS，WON JY，PARK SI，et al. Percutaneous peritoneovenous shunt creation for the treatment of benign and malignant refractory ascites[J]. J Vasc Interv Radiol，2001，12:1445-1448.
[43] ROSENBLUM DI，GEISENGER MA，NEWMANJS，et al. Use of subcutaneous venous access ports to treat refractory ascites[J]. J Vasc Interv Radiol，2001，12:1343-1346.
[44] ROZENBLIT GN，DELGUERCIO LRM，RUNDBACK JH，et al. Peritoneal-urinary drainage for treatment of refractory ascites:a pilot study[J]. J Vasc Interv Radiol，1998，9:998-1005.
[45] TROTTER J，PIERAMICI E，EVERSON GT. Chronic albumin infusions to achieve dieresis in patients with ascites who are not candidates for transjugular intrahepatic portosystemic shunt（TIPS）[J]. Dig Dis Sci，2005，50:1356-1360.
[46] ROMANELLI RG，LAVILLA G，BARLETTA G，et al. Long-term albumin infusionim proves survival in patients with cirrhosis and ascites:an unblinded randomized trial[J]. World J Gastroenterol，2006，12:1403-1407.
[47] LENAERTS A，CODDEN T，MEUNIER JC，et al. Effects of clonidine on diuretic response in ascitic patients with cirrhosis and activation of sympathetic nervous system[J]. Hepatology，2006，44:844-849.
[48] LENAERTS A，CODDEN T，HENRYJ-P，et al. Comparative pilot study of repeated large volume paracentesis vs the combination of clonidine-spironolactone in the treatment of cirrhosis-associated refractory ascites[J]. Gastroenterol Clin Biol， 2005，29:1137-1142.
[49] KAAMBOKIS G，FOTOPOULOS A，ECONOMOU M，et al. Octreotide in the treatment of refractory ascites of cirrhosis[J].Scand J Gastroenterol，2006，41:118-121. |
